PlaqueTec

About PlaqueTec

PlaqueTec is a cardiovascular medicine company focused on biomarker-based, personalised medicine strategies for coronary artery disease. It develops a novel Liquid Biopsy System to transform prevention, diagnosis and treatment of CAD, building cohorts to endotype disease and identify disease-specific drug targets. The company is based in Babraham, United Kingdom, and pursues precision medicine approaches to improve outcomes for patients with atherosclerotic cardiovascular disease.